June 8, 2023 C-Path and I-ACT Collaborate on EHR Data Transfer A Major Milestone for Pediatric Real-World Data Project TUCSON, Ariz., June 8, 2023 — Critical Path Institute‘s (C-Path) I
June 8, 2023 View Now: GUIDs and De-Identification Tools for Rare Diseases C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform is pleased to present this new webinar, GUIDs and De-Identi
June 7, 2023 Newcastle University’s John Walton Muscular Dystrophy Research Centre Contributes Data to C-Path’s RDCA-DAP TUCSON, Ariz., June 7, 2023 — Critical Path Institute (C-Path) announced today that Newcastle University UK’s John Walton Musc
June 7, 2023 Shaping the Global Innovation and Access Landscape for Better Paediatric Medicines: C-Path Becomes Official Partner of WHO TUCSON, Ariz. and AMSTERDAM, June 7, 2023 — Critical Path Institute (C-Path), a leading global nonprofit committed to expediting
June 7, 2023-June 8, 2023 Rare Disease Endpoint Advancement Pilot Program Workshop: Novel Endpoints for Rare Disease Drug Development Panel within a virtual workshop presented by The Duke-Margolis Center for Health Policy, under a cooperative agreement with the U.
June 6, 2023 ASCO Annual Meeting Join fellow oncology professionals at the 2023 ASCO Annual Meeting – a unique and unparalleled opportunity to connect with one o
May 31, 2023 C-Path’s Transplant Therapeutics Consortium’s Work Highlighted in Recent Publication in the American Journal of Transplantation C-Path’s Transplant Therapeutics Consortium is pleased to announce the recent publication in the American Journal of Transplan
May 31, 2023 CACNA1A Foundation to Contribute Data to C-Path’s RDCA-DAP, Accelerating Neurological Disease Research and Therapeutic Development TUCSON, Ariz., May 31, 2023 — Critical Path Institute (C-Path) announced today that the CACNA1A Foundation, a parent-led nonprof
May 24, 2023 Improving the Design of Clinical Trials in T1D: Analysis of Data from the Trial Outcome Markers Initiative (TOMI) Collaboration With presentations from JDRF, TrialNet and the TOMI-T1D Collaboration The Trial Outcome Marker Initiative brings together data fro
May 4, 2023 A Path to Real-World Evidence in Critical Care Using Open-Source Data Harmonization Tools COVID-19 highlighted the need for use of real-world data (RWD) in critical care as a near real-time resource for clinical...
